Pfizer (PFE) reported Q4 adjusted earnings Tuesday of $0.63 per diluted share, up from $0.10 a year earlier.
Analysts polled by FactSet expected $0.47.
Revenue for the quarter ended Dec. 31 was $17.76 billion, up from $14.57 billion a year earlier.
Analysts surveyed by FactSet expected $17.35 billion.
The company reaffirmed its 2025 adjusted earnings per share guidance of $2.80 to $3. Analysts surveyed by FactSet expect $2.91. The company also reiterated its annual revenue guidance of $61 billion to $64 billion. Analysts polled by FactSet expect $63.07 billion.
Shares of the company were up 2% in recent Tuesday premarket activity.
Price: 26.71, Change: +0.51, Percent Change: +1.95
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。